BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33457635
Number of visits today
7746
Number of downloads
16640823
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Li X, Cai H, Wu X, Li L, Wu H, Tian R. New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer. Front Chem 2020;8:583309. [PMID: 33335885 DOI: 10.3389/fchem.2020.583309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Silva MJSA, Vinck R, Wang Y, Saubaméa B, Tharaud M, Dominguez-Jurado E, Karges J, Gois PMP, Gasser G. Towards Selective Delivery of a Ruthenium(II) Polypyridyl Complex-Containing Bombesin Conjugate into Cancer Cells. Chembiochem 2023;24:e202200647. [PMID: 36479913 DOI: 10.1002/cbic.202200647] [Reference Citation Analysis]
2 DeRidder L, Rubinson DA, Langer R, Traverso G. The past, present, and future of chemotherapy with a focus on individualization of drug dosing. J Control Release 2022;352:840-60. [PMID: 36334860 DOI: 10.1016/j.jconrel.2022.10.043] [Reference Citation Analysis]
3 Bispo ACA, Almeida FAF, Silva JB, Mamede M. Peptides Radiofluorination: Main Methods and Highlights. IJOC 2022;12:161-172. [DOI: 10.4236/ijoc.2022.124013] [Reference Citation Analysis]
4 Slabáková E, Kahounová Z, Procházková J, Souček K. Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs. Noncoding RNA 2021;7:75. [PMID: 34940756 DOI: 10.3390/ncrna7040075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mansi R, Nock BA, Dalm SU, Busstra MB, van Weerden WM, Maina T. Radiolabeled Bombesin Analogs. Cancers (Basel) 2021;13:5766. [PMID: 34830920 DOI: 10.3390/cancers13225766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Nock BA, Kaloudi A, Kanellopoulos P, Janota B, Bromińska B, Iżycki D, Mikołajczak R, Czepczynski R, Maina T. [99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes. Cancers (Basel) 2021;13:5093. [PMID: 34680243 DOI: 10.3390/cancers13205093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345